Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-138,270
Closed -$3.5M 37
2021
Q4
$3.5M Sell
138,270
-966,320
-87% -$23M 0.54% 25
2021
Q3
$24.4M Sell
1,104,590
-455,595
-29% -$9.54M 4.16% 11
2021
Q2
$30.3M Buy
1,560,185
+114,215
+8% +$2.31M 5.01% 6
2021
Q1
$30.7M Buy
1,445,970
+145,375
+11% +$3.07M 5.4% 4
2020
Q4
$26.3M Sell
1,300,595
-356,030
-21% -$6.19M 5.63% 3
2020
Q3
$25.4M Sell
1,656,625
-56,700
-3% -$882K 6.31% 1
2020
Q2
$23.7M Buy
1,713,325
+434,400
+34% +$5.64M 6.29% 1
2020
Q1
$15.1M Buy
1,278,925
+61,595
+5% +$807K 5.5% 2
2019
Q4
$16.6M Buy
1,217,330
+97,050
+9% +$1.21M 3.92% 6
2019
Q3
$13.2M Buy
+1,120,280
New +$12.7M 3.13% 14

Other funds holding SONY

M.D. Sass LLC's SONY Position: Q1 2022 in Review

M.D. Sass LLC sold out of Sony (SONY) in Q1 2022, closing a stake of 138,270 shares — an estimated $3.5M sold.

M.D. Sass LLC first reported a position in SONY in Q3 2019 and held it in 10 quarters. The position peaked at $30.7M in Q1 2021. 607 funds tracked by Wall St. Rank hold SONY as of Q1 2022.

  • M.D. Sass LLC reported no remaining Sony position as of Q1 2022 after selling out during the quarter.
  • M.D. Sass LLC sold 138,270 Sony shares in Q1 2022, an estimated $3.5M.
  • M.D. Sass LLC first reported a position in Sony in Q3 2019 and held it in 10 quarters.
  • M.D. Sass LLC's Sony position peaked at $30.7M in Q1 2021.
  • 607 funds tracked by Wall St. Rank held Sony as of Q1 2022.

Based on M.D. Sass LLC's 13F filing for Q1 2022, filed 12 May 2022.